Review * Synthèse
Prostate cancer: 9. Treatment of advanced disease
M. E. Gleave, N. Bruchovsky, M. J. Moore and P. Venner
CMAJ January 26, 1999 160 (2) 225-232;
M. E. Gleave
N. Bruchovsky
M. J. Moore
In this issue
Article tools
Prostate cancer: 9. Treatment of advanced disease
M. E. Gleave, N. Bruchovsky, M. J. Moore, P. Venner
CMAJ Jan 1999, 160 (2) 225-232;
Related Articles
- No related articles found.
Cited By...
- Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor AZD5363
- Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer
- A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
- Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
- Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD
- The Fer Tyrosine Kinase Cooperates with Interleukin-6 to Activate Signal Transducer and Activator of Transcription 3 and Promote Human Prostate Cancer Cell Growth
- Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer?
- PSA screening: a view from the front lines